The Bladder Cancer Company

About Us

Our Values

Our History

Bladder cancer challenge

Board of directors

Executive Leadership

Leadership

Our Company

Photocure Technology

Our products

Research support

Innovation & Products

News

Bladder Cancer and AI

Addressing Inequality

Our Perspective

Patient Registries And Real-World Evidence

Bladder cancer community support

Corporate social responsibility

ESG Report

Our Impact

Why Partner with Photocure

Our Partners

Partners

Photocure culture

Working at Photocure

Careers

Contact

Events & Presentations

Financials

Shareholder information

FAQs

Investors hub

Investors

Press & Media

Privacy Policy

Terms of use

cevira

We use cookies to provide the best possible experience for you. By closing this message you agree to our use of cookies. You can learn more about cookies on our <a href="https://photocure.com/privacy-policy" target="_blank" rel="noopener noreferrer" aria-label="privacy page (opens in a new tab)" title="Opens in a new tab">privacy page</a>.

agree

The shares in Photocure ASA will be traded ex dividend NOK 4.00 as from today, 26 November 2009.

Ex dividend NOK 4.00 today

Financial Investment & Stock

Ex dividend NOK 4.00 today

News and events